Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

Cancer research - 1 Apr 2012

Noh Kyung Hee, Lee Young-Ho, Jeon Ju-Hong, Kang Tae Heung, Mao Chih-Ping, Wu T-C, Kim Tae Woo

Abstract excerpt

Due to the exquisite specificity and potency of the immune system, vaccination is in theory the most precise and powerful approach for controlling cancer. However, current data from clinical trials indicate that vaccination rarely yields significant benefits for cancer patients in terms of tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Homeodomain Proteins
Share to Immune Tolerance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nanog Homeobox Protein

Share to Neoplasms, Experimental

Share to Neoplastic Stem Cells

Share to T-Lymphocytes, Cytotoxic

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 22337995
DOI: 10.1158/0008-5472.CAN-11-3758
PMCID: PMC3319841

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22337995-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.PMID 22337995Read ↗

Nanog signaling in cancer promotes stem-like phenotype and immune evasionSemantic proximity Read ↗

Spatiotemporal dynamics of adoptively transferred stem-like CD8 <sup>+</sup> T cells in the tumor microenvironment following vaccinationSemantic proximity Read ↗

Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6.Semantic proximity Read ↗

Cancer cells escape the immune system by increasing stemness through epigenetic reprogrammingSemantic proximity Read ↗

Vaccination rescues dysfunctional T cell therapy by amplifying rare stem-like antitumor CD8⁺ T cellsSemantic proximity Read ↗

Hide-and-seek: the interplay between cancer stem cells and the immune systemSemantic proximity Read ↗

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapySemantic proximity Read ↗

Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsSemantic proximity Read ↗

Targeting cancer stem cells: emerging role of Nanog transcription factorSemantic proximity Read ↗

CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancersSemantic proximity Read ↗

The oncogenic potential of NANOG: An important cancer induction mediatorSemantic proximity Read ↗

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.